Potential of polyphenols to restore SIRT1 and NAD+ metabolism in renal disease

C Tovar-Palacio, LG Noriega, A Mercado - Nutrients, 2022 - mdpi.com
SIRT1 is an NAD+-dependent class III histone deacetylase that is abundantly expressed in
the kidney, where it modulates gene expression, apoptosis, energy homeostasis …

Renal protective effect of sirtuin 1

Y Dong, N Liu, Z **ao, T Sun, S Wu… - Journal of diabetes …, 2014 - Wiley Online Library
Silent information regulator 2 (Sir2) is a nicotinamide adenine dinucleotide‐(NAD+‐)
dependent deacetylase. The homology of SIRT1 and Sir2 has been extensively studied …

Dipeptidase-1 governs renal inflammation during ischemia reperfusion injury

A Lau, JJ Rahn, M Chappellaz, H Chung… - Science …, 2022 - science.org
The mechanisms that drive leukocyte recruitment to the kidney are incompletely understood.
Dipeptidase-1 (DPEP1) is a major neutrophil adhesion receptor highly expressed on …

[HTML][HTML] Zingerone ameliorates cisplatin‐induced ovarian and uterine toxicity via suppression of sex hormone imbalances, oxidative stress, inflammation and …

C Caglayan, FM Kandemir, S Yıldırım… - Biomedicine & …, 2018 - Elsevier
Cisplatin (CP) is a widely used chemotherapeutic drug, effective against a variety of solid
tumours, though its utility is limited due to its multiple organ toxicity. Zingerone (ZO), one of …

ELABELA and an ELABELA fragment protect against AKI

H Chen, L Wang, W Wang, C Cheng… - Journal of the …, 2017 - journals.lww.com
Renal ischemia-reperfusion (I/R) injury is the most common cause of AKI, which associates
with high mortality and has no effective therapy. ELABELA (ELA) is a newly identified 32 …

ATP/ADP biosensor organoids for drug nephrotoxicity assessment

K Susa, K Kobayashi, P Galichon… - Frontiers in Cell and …, 2023 - frontiersin.org
Drug nephrotoxicity is a common healthcare problem in hospitalized patients and a major
limitation during drug development. Multi-segmented kidney organoids derived from human …

Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats

W Arjumand, A Seth, S Sultana - Food and chemical toxicology, 2011 - Elsevier
Cisplatin is an effective chemotherapeutic agent that displays dose-limiting nephrotoxicity. In
the present study the wistar rats were subjected to concurrent prophylactic oral treatment of …

Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injury

A Lau, H Chung, T Komada, JM Platnich… - The Journal of clinical …, 2018 - jci.org
Radiographic contrast agents cause acute kidney injury (AKI), yet the underlying
pathogenesis is poorly understood. Nod-like receptor pyrin containing 3–deficient (Nlrp3 …

Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity

PD Sanchez-Gonzalez… - Nephrology Dialysis …, 2011 - academic.oup.com
Background. Nephrotoxicity is the major limitation for the clinical use of cisplatin as an anti-
tumoural drug. Our aim was to investigate the protective effect of quercetin on cisplatin …

Protective and therapeutic efficacy of hesperidin versus cisplatin against ehrlich ascites carcinoma-induced renal damage in mice

N Saleh, T Allam, RMS Korany, AM Abdelfattah… - Pharmaceuticals, 2022 - mdpi.com
This study evaluates the antitumor efficacy of hesperidin (Hesp) versus cisplatin (Cis) in
Ehrlich ascites carcinoma (EAC)-bearing mice, as well as its protective effect against Cis …